Retatrutide is a new medication in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, https://deborahozhq388257.creacionblog.com/35930287/retatrutide-a-promising-new-treatment-for-obesity